India's Supreme Court on Monday pressed the government to cap prices of all non-patented drugs and medical consumables, not just anti-cancer medicines. The bench cited margins reaching 1,000% and asked why patients should be fleeced, while the government defended higher rural margins and market competition. The case was adjourned to October 27.
Supreme Court Urges Price Controls on All Non-Patented Medicines
Source: Times of India